Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Mersana Therapeutics Inc (NASDAQ: MRSN) was $2.22 for the day, up 3.74% from the previous closing price of $2.14. In other words, the price has increased by $3.74 from its previous closing price. On the day, 1.06 million shares were traded. MRSN stock price reached its highest trading level at $2.23 during the session, while it also had its lowest trading level at $2.0992.
Ratios:
Our analysis of MRSN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.51 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 0.87.
On February 29, 2024, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $7.
Guggenheim Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 16 ’24 when Protopapas Anna sold 29,399 shares for $2.71 per share. The transaction valued at 79,671 led to the insider holds 125,153 shares of the business.
Lowinger Timothy B sold 10,409 shares of MRSN for $28,208 on Jan 16 ’24. The SVP, Chief Sci.&Tech. Officer now owns 199,329 shares after completing the transaction at $2.71 per share. On Jan 16 ’24, another insider, DeSchuytner Brian, who serves as the SVP, COO & CFO of the company, sold 9,327 shares for $2.71 each. As a result, the insider received 25,276 and left with 54,511 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 271641408 and an Enterprise Value of 122210944. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.09 while its Price-to-Book (P/B) ratio in mrq is 9.71. Its current Enterprise Value per Revenue stands at 3.191 whereas that against EBITDA is -0.922.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $9.62, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is -29.31%, while the 200-Day Moving Average is calculated to be -16.36%.
Shares Statistics:
MRSN traded an average of 1.95M shares per day over the past three months and 1722780 shares per day over the past ten days. A total of 120.71M shares are outstanding, with a floating share count of 91.67M. Insiders hold about 25.08% of the company’s shares, while institutions hold 74.74% stake in the company. Shares short for MRSN as of 1715731200 were 8989035 with a Short Ratio of 4.60, compared to 1713139200 on 10580194. Therefore, it implies a Short% of Shares Outstanding of 8989035 and a Short% of Float of 9.67.
